Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 208,343 | 69,429 | 78,530 | 224,254 | 125,575 |
| Marketable Securities | 182,915 | 221,165 | 247,544 | 147,895 | 116,611 |
| Receivables | 4,965 | 2,370 | 1,408 | 173 | 595 |
| TOTAL | $401,817 | $299,465 | $332,280 | $377,440 | $251,207 |
| Non-Current Assets | |||||
| PPE Net | 27,598 | 29,052 | 29,336 | 29,483 | 31,442 |
| Other Non-Current Assets | 30,426 | 31,069 | 31,583 | 31,809 | 32,431 |
| TOTAL | $58,024 | $60,121 | $60,919 | $61,292 | $63,873 |
| Total Assets | $459,841 | $359,586 | $393,199 | $438,732 | $315,080 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,509 | 5,581 | 6,489 | 17,215 | 3,978 |
| Accrued Expenses | 17,902 | 13,767 | 16,287 | 18,785 | 15,099 |
| TOTAL | $61,443 | $41,852 | $59,216 | $156,946 | $41,641 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 24,791 | 18,410 | 32,575 | 117,232 | 18,918 |
| Other Non-Current Liabilities | 35,927 | 37,037 | 37,999 | 39,001 | 40,052 |
| TOTAL | $152,561 | $49,654 | $58,823 | $58,850 | $67,982 |
| Total Liabilities | $214,004 | $91,506 | $118,039 | $215,796 | $109,623 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,118 | 61,759 | 61,510 | 61,510 | 61,437 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -431,079 | -403,998 | -391,703 | -438,588 | -452,025 |
| Other shareholders' equity | -3,247 | -3,373 | -3,329 | -3,356 | -2,322 |
| TOTAL | $245,837 | $268,080 | $275,160 | $222,936 | $205,457 |
| Total Liabilities And Equity | $459,841 | $359,586 | $393,199 | $438,732 | $315,080 |